CMS
Owners of California Mobile Phlebotomy Company Plead Guilty to $7.5M Fraud Scheme
The owners billed Medicare for services not reimbursed by Medicare and in their bills overstated the mileage traveled by their company's phlebotomists.
HHS OIG Report Finds Medicare Spending on Lab Tests Increased 17 Percent in 2021
Spending increased to $9.3 billion in 2021, up from $8.0 billion in 2020 and the biggest change in spending since OIG began monitoring payments in 2014.
While reform of lab-developed test regulations and PAMA appeared possible at the beginning of 2022, in the end, the status quo won out.
Georgia Lab Owner Convicted of $463M Medicare Genetic Testing Fraud Scheme
The man promoted and sold medically unnecessary tests to Medicare beneficiaries then paid kickbacks to get signed doctors' orders for those tests.
Top Five Articles on 360Dx Last Week: RADx's Legacy; Roche Alzheimer's Test Gets FDA Nod; and More
Last week, readers were most interested in how the RADx program changed COVID-19 testing development and its potential effect on the Dx market.
Dec 8, 2022
Oct 18, 2022
Aug 19, 2022
Aug 5, 2022
Jul 6, 2022
Jun 30, 2022
Jun 6, 2022